DPP4 and type 2 diabetes mellitus: DPP-4 inhibitors (DPP-4i) represent a class of oral antihyperglycemic agents used for the treatment of Type 2 diabetes (T2D) [14], which have also been reported to play anti-inflammatory and immunomodulatory properties [15].